Ginkgo Bioworks Holdings, Inc.

Ginkgo Bioworks Holdings, Inc. completed its path to public markets through a merger with Soaring Eagle Acquisition Corp. (Nasdaq: SRNG), a blank-check company sponsored by Eagle Equity Partners and co-led by veteran deal makers Harry Sloan and Jeff Sagansky. Soaring Eagle priced its IPO in March 2021, targeting the technology and life sciences sectors, before closing its business combination with synthetic biology company Ginkgo Bioworks in September 2021; the merged entity subsequently listed as DNA on the New York Stock Exchange. An S-1/A registration statement amendment was filed on September 27, 2022, reflecting post-merger registration activity. Sign up on SpacDesk for full filings, timeline data, and analytics on this and every SPAC transaction.